Deep Ocean off Southern Greece to Be Field Test Site for Finalists in the $7M Shell Ocean Discovery XPRIZE
XPRIZE, the global leader in designing and operating world-changing incentive competitions, today announced the deep sea off Kalamata, Greece, has been chosen as the field testing location for finalist teams competing in the $7M Shell Ocean Discovery XPRIZE. Deep sea, real-world testing is a key stage in the three-year global competition challenging teams to advance ocean technologies for rapid, unmanned and high-resolution ocean exploration and discovery. In this final field-testing round for the Grand Prize of the competition, which starts in November and runs through December, the teams have up to 24 hours to map at least 250 km2 of the ocean seafloor - an area that is nearly three times the area of Paris - to depths down to 4,000 meters – a cold, dark and high-pressure environment that is more than twice as deep as the Grand Canyon.
On the southern coast of Greece, each team will launch and recover their autonomous underwater technologies from XPRIZE’s Mission Control in Kalamata. The competition area is approximately 500 km2 and includes a number of underwater features. Finalist teams have to launch from shore and their entries must travel to the competition location by water or air and, with restricted human intervention, map at least 50 percent of the area – 250 km2 – at five meters resolution and at depths down to 4,000 meters, identifying and imaging at least ten archeological, biological or geological features at any depth, all within 24 hours.
“We are excited to be bringing this XPRIZE to Greece, an amazing country with a long history of scientific and technological advancements that have benefited the world,” said Jyotika Virmani, Ph.D., prize lead and senior director of XPRIZE’s Planet and Environment team. “The Shell Ocean Discovery XPRIZE competing teams are creating breakthrough technologies designed to operate in extreme conditions, with the goal of rapidly mapping an area that has not previously been mapped at such high resolution; we are providing the teams with an environment that is full of mystery and geological features that will offer a true test of their technologies.”
The Shell Ocean Discovery XPRIZE has the support of the Government of Greece, including the Ministries of Foreign Affairs, Maritime Affairs and Insular Policy, Education, Research and Religious Affairs, Shipping, and Culture and Sports. The operational team is also working with multiple other organizations, including the National Centre of Scientific Research Demokritos, Office of the Mayor of Kalamata, Municipal Port Fund of Kalamata, Hellenic Coast Guard/Central Port Authority, and the Hellenic Center for Marine Research to ensure smooth operations by providing logistical assistance. Competition organizers also continue to work with Fugro, an industry leader in ocean mapping; and Esri, the global leader in geographic information system (GIS) software. XPRIZE is also partnering with Singularity University, which is hosting the SingularityU Greece Summit in November, at which Dr. Peter H. Diamandis, founder and executive chairman of XPRIZE, will give the opening keynote and Dr. Virmani will discuss the Shell Ocean Discovery XPRIZE.
“We are proud that Kalamata was chosen to be the host city to this international competition and are happy to be able to provide the infrastructure and logistics to support the demonstration of new and exciting technologies,” said Panagiotis Nikas, mayor of Kalamata. “The waters surrounding Kalamata provide teams in the Shell Ocean Discovery XPRIZE with a unique and varied underwater landscape for exploration, and we look forward to supporting their work in this important final round of real-world testing.”
At the end of the competition, a $4M Grand Prize and $1M Second Place Prize will be awarded to the teams that receive the top scores for demonstrating the highest resolution seafloor mapping. After the competition has ended, the high-resolution seafloor map will be used by NCSR-Demokritos, the largest research center in Greece, and their Institute of Nuclear and Particle Physics as part of a worldwide scientific collaboration to establish a new generation Neutrino telescope in the Mediterranean.
A secondary test location to support the National Oceanic and Atmospheric Administration (NOAA) $1M Bonus Prize will take place in early 2019, once the Grand Prize testing has been completed. This will give all Bonus Prize finalist teams an opportunity to test their technologies and will determine the Bonus Prize winner. In this prize, competing teams will need to demonstrate that their technology can “sniff out” a specified object in the ocean by tracing a biological or chemical signal to its source.
XPRIZE, a 501(c)(3) nonprofit, is the global leader in designing and implementing innovative competition models to solve the world’s grandest challenges. Active competitions include the Lunar XPRIZE, the $20M NRG COSIA Carbon XPRIZE, the $15M Global Learning XPRIZE, the $10M ANA Avatar XPRIZE, the $7M Shell Ocean Discovery XPRIZE, the $7M Barbara Bush Foundation Adult Literacy XPRIZE, the $5M IBM Watson AI XPRIZE and the $1.75M Water Abundance XPRIZE. For more information, visit www.xprize.org.
Shell companies have been technology pioneers for more than 100 years, and have come up with many industry-transforming “firsts” to deliver energy to its customers. Since 2007, Shell has spent more than $1 billion annually on research and development. In 2014, our research and development expenditures were $1.2 billion, and Shell’s technical and engineering staff number more than 43,000 people.
Shell companies have operations in more than 70 countries and territories with businesses including oil and gas exploration and production; production and marketing of liquefied natural gas and gas to liquids; manufacturing, marketing, and shipping of oil products and chemicals and renewable energy projects. Royal Dutch Shell plc is incorporated in England and Wales, has its headquarters in The Hague, and is listed on the London, Amsterdam, and New York stock exchanges. For further information, visit www.shell.com.
About National Oceanic and Atmospheric Administration (NOAA)
The National Oceanic and Atmospheric Administration (NOAA) is a science-based federal agency within the Department of Commerce with regulatory, operational, and information service responsibilities with a presence in every state and U.S. territories. NOAA's mission is to understand and predict changes in the Earth's environment, from the depths of the ocean to the surface of the sun, and to conserve and manage coastal and marine resources. For more information, visit www.noaa.gov.
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Aroma Bit to Develop Smartphone Embeddable Ultra-compact Silicon CMOS Based Smell Sensor That Has Dog Nose Equivalent Resolution in 1mm Squared Die Size23.7.2019 04:30:00 EEST | Press release
Aroma Bit launched a new subsidiary to develop the next generation smell sensor based on silicon CMOS sensor substrate that are ultra-compact, high resolution and low cost. The technology is realized by applying Aroma Bit developed smell sensor receptor membrane technology to ultra-sensitive silicon CMOS based ion imaging sensor technology developed by professor Kazuaki Sawada at Toyohashi University of Technology and associated companies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190722005004/en/ Picture of 1mm squared die of silicon CMOS based smell sensor, with dog nose equivalent ~1,200 sensor pixels (Photo: Business Wire) Aroma Bit: http://www.aromabit.com Realizing smartphone embeddable smell sensor with dog nose equivalent ultra-high resolution smell sensor on only 1 millimeter square silicon die size Aroma Bit has developed and are currently selling a compact smell sensor that employs QCM or Quartz Crystal Micro
Logitech Delivers a Strong Start to Fiscal Year 2020 with Robust Sales and Profit Growth23.7.2019 04:00:00 EEST | Press release
Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced financial results for the first quarter of Fiscal Year 2020. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190722005781/en/ Logitech delivers a strong start to Fiscal Year 2020 with robust sales and profit growth. (Graphic: Business Wire) Q1 sales were $644 million, up 6 percent in US dollars and 9 percent in constant currency, compared to Q1 of the prior year. Q1 GAAP operating income grew 46 percent to $47 million, compared to $32 million in the same quarter a year ago. Q1 GAAP earnings per share (EPS) grew 17 percent to $0.27, compared to $0.23 in the same quarter a year ago. Q1 non-GAAP operating income grew 11 percent to $67 million, compared to $61 million in the same quarter a year ago. Q1 non-GAAP EPS grew 15 percent to $0.39, compared to $0.34 in the same quarter a year ago. Cash flow from operations was $37 million, compared to $12 million in the sa
Gilead Presents New Data on Biktarvy® for the Treatment of HIV in Women and in Virologically Suppressed Patients With Known Resistance22.7.2019 19:00:00 EEST | Press release
Gilead Sciences, Inc. (NASDAQ: GILD) today presented findings from two Phase 3 trials – a trial demonstrating the effectiveness of switching to Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg tablets, B/F/TAF) in women, and a trial evaluating the potential for the single tablet regimen to be an effective treatment option in virologically suppressed patients with known resistance to nucleo(s)tide or non-nucleo(s)tide reverse transcriptase inhibitors (NRTIs or NNRTIs). The use of Biktarvy in patients with known drug resistance is investigational. These data were presented at the 10th International AIDS Society Conference on HIV Science (IAS 2019) being held in Mexico City. “These data presented at IAS provide new information about the treatment of HIV among women and patients with known drug resistance,” said Diana Brainard, MD, Senior Vice President, HIV and Emerging Viruses, Gilead Sciences. “The studies further demonstrate the potential for Biktarvy to be an
IBC Celebrates Young Talent in the Industry22.7.2019 18:36:00 EEST | Press release
The media, entertainment and technology industry is changing. Attitudes are shifting, the next generation is consuming content differently to any before them and diverse and exciting content is being created to meet that demand in innovative formats. Driving this change is a new wave of industry talent, honoured at IBC with the first IBC Young Pioneer Award. Recognising the brightest, newest talent in the industry, this award will go to someone who has made a real impact with their passion, ambition and commitment and is making an outstanding contribution to our industry. “What we were looking for in the shortlist was, most importantly, real talent, a stand-out individual making a real difference in the industry,” said David Levine, VP, Programming - Kids, Europe & Africa/UK & Ireland, The Walt Disney Co. Ltd and Chair of the Judging Panel. “But we were also looking for a lasting legacy, for the Young Pioneer to be a leader today and a media guru of the future.” The call for entries so
Gilead Presents Proof-of-Concept Data for GS-6207, a First-in-Class Capsid Inhibitor, in People Living With HIV22.7.2019 18:00:00 EEST | Press release
Gilead Sciences, Inc. (NASDAQ: GILD) today presented the first clinical data in people living with HIV on GS-6207, an investigational, novel, selective, first-in-class inhibitor of HIV capsid function. The Phase 1b data demonstrate the first proof of concept that HIV capsid inhibition can lead to significant declines in viral load in vivo. In addition, Gilead presented preclinical data demonstrating that resistance to GS-6207 in vitro did not lead to resistance to other classes of drugs used in the treatment of HIV. These data were presented at the 10th International AIDS Society Conference on HIV Science (IAS 2019) in Mexico City. GS-6207 is an investigational long-acting antiretroviral agent that can be delivered subcutaneously. GS-6207 recently received breakthrough therapy designation from the U.S. Food and Drug Administration (FDA) as a potential therapy for heavily treatment-experienced people living with multi-drug resistant HIV. GS-6207 acts in a novel way compared with current
Pacific Drilling Appoints James W. Harris as Chief Financial Officer22.7.2019 16:42:00 EEST | Press release
Pacific Drilling S.A. (NYSE: PACD), one of the world’s leading deepwater drilling contractors, today announced that Pacific Drilling’s Board has appointed James W. Harris to serve as the Company’s Senior Vice President and Chief Financial Officer. Mr. Harris replaces Mr. Johannes (John) P. Boots, who, as previously announced, mutually agreed with the Company to step down from his position to pursue other opportunities. Mr. Harris has more than 30 years of experience in the energy industry in a variety of financial leadership, strategic and business planning roles. He most recently served as Executive Vice President, Drilling & Subsea for Forum Energy Technologies, Inc., having previously served Forum as Chief Financial Officer for 12 years. Bernie Wolford, the Company’s Chief Executive Officer, stated, “We sincerely appreciate the many contributions that John has made during his nearly 10-year tenure with Pacific Drilling and we wish him all the best in his future endeavors.” “We are e
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom